1. Field of the Invention
The present invention is concerned with implantable orthopedic devices that prevent the loss of bone, stimulate the growth of bone tissue, and enhance fracture healing.
2. Description of the Prior Art
Osteoporosis and other degenerative diseases, including bone trauma, often require the surgical insertion of a prosthetic implant to replace the damaged tissue. The implant must be biocompatible and have the same structural integrity as the tissues it replaces. Replacement of the joints in the hip may require the use of artificial components, in the form of a prosthetic implant inserted into the femur and corresponding acetabulum forming the replacement joint. The knee joint is replaced with two corresponding components, inserted into the femur and tibia, forming the knee joint. These prosthetic implants have been made of stainless steel, cobalt-chromium-molybdenum alloys, titanium alloys, ceramics, and other materials. In order for these materials to be effective as a long term replacement of the joint, the prosthetic implant must provide a good substrate into which the surrounding bone can mechanically integrate and achieve long-term stability. Though much research has been devoted to this concept, these materials fail to achieve excellent mechanical integration and the failure rate of these devices remains high.
Many prosthetic implants have been developed to address implant failure by attempting to enhance the mechanical integration between the implant and the bone. Two such methods stabilizing implantable prosthetic devices are the use of polymethyl methacrylate (PMMA) bone cement and the application of a porous coating on the surface of the implant. The PMMA bone cement can cause harmful side effects and can cause osteolysis which leads to implant failure. In addition, the body may, in response to the implant, form a fibrous tissue capsule surrounding the implant, which causes loosening and failure of the prosthetic device. Failure can also occur if the bone cement fractures or weakens. The technique of porously coating the prosthesis with sintered beads was developed for press-fit implants. These implants do not require cement and achieve a scratch fit against the bone. The bone grows in a three-dimensional nature around these beads, which stabilizes the implant. The porous coat can be applied to either the entire surface, or to proximal sections of the implant so as to facilitate mechanical bonding. The porous coat may also vary according to the size of the sintered bead, which is believed to stimulate different amounts of bone bonding to the implant. This method has had short term success in achieving a mechanical interface with the surrounding bone tissue; however, this application fails in the long-term because of stress shielding, an uneven transfer of weight-bearing stresses to the bone. The porous coat also does not induce a uniform attachment of the bone to the implant substrate which often causes failure of the implant. Lastly, the rate at which the surrounding bone tissue grows into the implant remains slow, which calls for extensive recovery time and there is an increased potential to develop complications.
Bone responds to varying applied stresses and will remodel to best suite those stresses, as recognized by Wolff in 1892. A typical implant reduces stress transfer to the bone in proximal areas around femoral hip implants, while increasing stress transfer in distal areas. This leads to hip pain and eventual bone fracture.
Bone has the ability to detect an externally applied load as a mechanical strain and respond to that strain via tissue remodeling. When stress is applied to a bone in a body, certain materials in bone tissue polarize and exhibit piezoelectric properties. A voltage develops along the loading axis, which stimulates osteoblast cells in the bone matrix to form new bone. At the same time, osteoclast cells break down bone which may account for the similarity in the rates of new bone formation and old bone breakdown, which may maintain bone distribution and bone density at a substantially uniform level. When an orthopedic femoral hip implant is placed in the body, the natural loading environment of the body changes as the regions proximal to the implant receive decreased levels of stress as compared to distal regions. The ultimate result of this phenomenon may be the failure of the implanted prosthesis which will necessitate further surgery.
Attempts have been made to chemically bond implants to bone tissue by the use of a coating of hydroxyapatite or other similar calcium containing chemical compounds. The chemical bonding stabilizes the implant by filling in gaps and providing a cementing effect. The use of chemical compounds does address the problem of protecting the implant from stresses which can cause the implant to loosen and fail. Piezoelectric materials have been used in connection with implants to stimulate bone growth. U.S. Pat. No. 6,143,035 utilizes surface applied piezoelectric elements that are attached to a hip implant with the outer surface polarized to have a negative charge. The piezoelectric element is placed on the medial side of the shoulder or neck of the implant where it will undergo compressive strain. Other embodiments used piezoelectric elements that were mounted on a bone in a position remote from the area where bone growth was desired. Electrical conductors were implanted to conduct the remotely generated current to the site where an implant is placed.
U.S. Pat. No. 6,571,130 discloses a biocompatible piezoelectric element for use as an implanted sensor. U.S. Pat. No. 6,447,542 discloses an implantable porous member that has pores which may be filled with a piezoelectric composition which has the ability to stimulate cell growth by generating an electrical field in response to mechanical stress.
The form and function of the musculo-skeletal system is closely related to the forces acting in its components. Fracture treatment by means of intramedullary nails is an accepted and widely used method of treating transverse and short oblique, axially stable fractures of the femoral diaphysis. However, complications may arise during fracture healing and non-unions, delayed unions, and mal-unions have been reported as well. The introduction of the interlocking nail has allowed treatment of comminuted femoral fractures, because limb rotation and length can be maintained but healing is still a problem in many cases. In femoral nailing, two treatment modalities can be discerned: Static locking connects the implants with the main proximal and distal bone fragments, securing their relative position and orientation. Dynamic locking with fewer connecting screws should prevent rotation while allowing dynamic interfragmentary compression. Experimentally, the beneficial effects of electricity in bone healing have been demonstrated in long bone fracture models. In 1957, Fukada and Yasuda (J.Physiol Soc Jpn 12:1158-1162(1957)) showed that a continuous current of 1 μA over 3 weeks produce new bone growth in rabbit femora. Direct current delivered via electrodes in long bones results in osteogenesis around the negative electrode and resorption around the positive electrode. Ultrasound emitting devices and capacitive coupling devices have been shown to reduce the rates of delayed unions and non-union fractures. Therefore, the present invention also includes the use of direct current stimulation of bone growth by imbedding piezoelectric elements into intramedullary rods and interlocking nails.
The prior art does not disclose the concept of providing below the surface mounted, discrete piezoelectric elements that are positioned in an implantable device in such a manner that they are separated from one another and extend slightly from the surface of the implant, are slightly below the surface of the implant or are flush with the surface of the implant. The use of spaced apart individual piezoelectric elements is believed to make possible the provision of more effective electrical fields for the stimulation of bone growth by locating the piezoelectric elements where the bone growth is more important to the long term success of the implant. For example, in the case of a hip implant, bone growth at the upper end of the femur is more important than in other areas contacted with the implant because of the higher stresses that are applied to the upper end of the femur.
The present invention provides an orthopedic device adapted for implantation into a body where it contacts bone tissue, said device having at least one spaced apart polarized magnetic element, at least one piezoelectric element or a combination of a polarized magnetic element and a piezoelectric element which are in direct contact with one another or are separately mounted on said device, said element being at least partially embedded in a surface of said device which contacts bone tissue, said element being positioned to be in direct electrical contact with bone tissue for the promotion of osteogenesis or osseointegration.
Accordingly, it is a principal object of this invention to provide improved orthopedic implant devices that have embedded in a surface a material that promotes osteogenesis or osseointegration.
It is also an object of the invention to provide improved methods and produce internal fixation devices to promote the healing of fractures.
It is also an object of this invention to reduce the time required for complete healing of bone trauma after the implantation of orthopedic devices.
The present invention is an improved implantable orthopedic device that is intended to provide accelerated or enhanced bone formation around the implant as compared to the normal bone growth that occurs in response to the implantation of artificial materials in the body. The particular implants that may be adapted for use in connection with the invention include virtually all implantable devices such as dental implants, hip joints, knee joints, finger joints, bone fixation devices, spinal implants, intramedullary rods, intramedullary nails, and the like, whether for human or veterinary applications.
The piezoelectric element that is used in the invention may be made of any non-toxic, biocompatible material that will generate an amount of electric current that will stimulate bone growth under the normal stress that bone structure receives due to walking, running, standing, chewing and the like. The current that is generated by the piezoelectric element should be between 1 and 250 microamps/cm2, preferably 1-30 microamps/cm2 and should have a voltage of between 0.1 microvolt/cm2 and 10 volts/cm2 of bone tissue but preferably between 1 microvolt/cm2 and 300 microvolts/cm2. The materials that may be used to make the piezoelectric elements are commercially available as are the complete piezoelectric elements. Examples of materials that may be used to make suitable piezoelectric elements include barium titanate, hydroxyapatite, apatite, sodium potassium niobate, quartz, PZT (lead zirconium titanate), electret polymers and the like which are mixed with conventional binders and formed into discrete piezoelectric elements. The preferred shape has a circular profile, such as a cylinder with the positive end substantially flat and the other or outer end having a domed shape which is adapted to slide along a bone surface when it is fitted into a bone shaft. The elements may be from 0.02 mm to 2 mm high with a diameter from 1 mm to 5 mm. Other shapes having flat surfaces and squared edges may be utilized. The piezoelectric elements can be polarized in either shear or normal modes. The circular configuration is preferred because drilled holes may be used to facilitate the embedding of the piezoelectric elements in a surface of an implant in implants having a large surface area. In a knee joint, the piezoelectric element may have a ring shape that is placed around the upper and lower post where it is embedded in the transverse surface that abuts each post. A ring shaped piezoeleetric element is placed circumferentially around a medullary nail implant where it is embedded below the metal surface with the upper end being either co-planar with the implant surface or being extended above the surface of the implant. In a bone screw, a ring is placed around the shaft of the screw which abuts the screw head where it is embedded in the transverse surface of the screw head and may also be incorporated into the threaded region of the shaft of the screw body.
Generally more than one piezoelectric element will be positioned in an implant to obtain maximum bone growth stimulation without causing any adverse effects. In a hip joint implant, for example, 10-20 individual piezoelectric elements may be embedded in the surface at the upper quarter of the shaft of the hip implant as shown in
Generally in implants where a plurality of piezoelectric elements is utilized, the piezoelectric elements will be spaced apart from one another so that they are spaced from 5 to 500 mm, or more preferably from 5-25 mm apart, depending on the particular implant. It is to be understood that in the case of a knee implant the embedded piezoelectric element may be a single ring like structure which is sized to fit around the individual posts and to fit into a recess around the bottom of the post. The implant maybe affixed to an implant by forming a hole such as a dimple. A dimple is defined to be an indent or a pore which extends below the surface to create a void in any part of the implant that will contact bone tissue. The piezoelectric element may be fixed in the dimple by press fitting a sized piezoelectric element, by an adhesive or by use of machine cut threads, or by forming the piezoelectric element in situ during manufacturing. The negative or the positive pole of the piezoelectric element will be oriented to the outer surface of the implant. The piezoelectric element maybe electrically insulated from the sides of the dimple to enhance the current flow from the implant to the bone tissue. This electric insulation may be any biocompatible dielectric material such as biocompatible glasses or polymers such as ultrahigh molecular weight polyethylene or titanium oxide.
In conjunction with the piezoelectric elements on the surface of an implant, it may be desired to utilize a coating such as hydroxyapatite or other bone growth stimulants or drugs such as resorbable scaffold polymers such as PLA (polylactic acid) or PLLA (poly-L-lactide) or PGA (polyglycolic acid) or antibiotics. As best seen in
As shown in
This application claims the priority of Ser. No. 60/649,968, filed Feb. 4, 2005.
Number | Name | Date | Kind |
---|---|---|---|
3820534 | Kraus et al. | Jun 1974 | A |
4027392 | Sawyer et al. | Jun 1977 | A |
4175565 | Chiarenza et al. | Nov 1979 | A |
4195367 | Kraus | Apr 1980 | A |
4216548 | Kraus | Aug 1980 | A |
4558701 | Spalten | Dec 1985 | A |
4665920 | Campbell | May 1987 | A |
4698318 | Vogel et al. | Oct 1987 | A |
4895574 | Rosenberg | Jan 1990 | A |
5030236 | Dean | Jul 1991 | A |
5032129 | Kurze et al. | Jul 1991 | A |
5298602 | Shikinami et al. | Mar 1994 | A |
5383935 | Shirkhanzadeh | Jan 1995 | A |
5456724 | Yen et al. | Oct 1995 | A |
5684061 | Ohnishi et al. | Nov 1997 | A |
5733292 | Gustilo et al. | Mar 1998 | A |
5759205 | Valentini | Jun 1998 | A |
5876446 | Agrawal et al. | Mar 1999 | A |
6034295 | Rehberg et al. | Mar 2000 | A |
6120502 | Michelson | Sep 2000 | A |
6143035 | McDowell | Nov 2000 | A |
6168633 | Shoher et al. | Jan 2001 | B1 |
6241771 | Gresser et al. | Jun 2001 | B1 |
6368325 | McKinley et al. | Apr 2002 | B1 |
6447542 | Weadock | Sep 2002 | B1 |
6481440 | Gielen et al. | Nov 2002 | B2 |
6526984 | Nilsson et al. | Mar 2003 | B1 |
6571130 | Ljungstrom et al. | May 2003 | B1 |
6605089 | Michelson | Aug 2003 | B1 |
20010008980 | Gresser et al. | Jul 2001 | A1 |
20030040806 | MacDonald | Feb 2003 | A1 |
20040122521 | Lee et al. | Jun 2004 | A1 |
20040199219 | Dodge et al. | Oct 2004 | A1 |
20050228503 | Gundolf | Oct 2005 | A1 |
Number | Date | Country |
---|---|---|
07096042 | Apr 1995 | JP |
1122329 | Nov 1984 | SU |
WO 9533416 | Dec 1995 | WO |
Number | Date | Country | |
---|---|---|---|
20060190080 A1 | Aug 2006 | US |
Number | Date | Country | |
---|---|---|---|
60649968 | Feb 2005 | US |